Genetics of familial pulmonary fibrosis and other variants

Idiopathic Pulmonary Fibrosis

Volumn , Issue , 2003, Pages 31-54

  Wahidi, Momen M ^a   Schwartz, David A ^a   Raghu, Ganesh ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33744905041     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (143)

1. King T, Costabel U, Cordier J, DoPico G, du Bois R, Lynch D, Myers J, Panos R, Raghu G, Schwartz D, Smith C, Corn J. International consensus statement idiopathic pulmonary fibrosis: diagnosis and treatment. Am J Respir Crit Care Med 2000; 161: 646–664.
2. Sandoz E. Uber zwei Falle von fotaler Bronchektasie. Beitr Pathol Anat 1907; 41: 495–516.
3. Hamman L, Rich A. Fulminating diffuse interstitial fibrosis of the lungs. Tr Am Clin Climat Assoc 1935; 51: 154–163.
4. Javaheri S, Lederer DH, Pella JA, Mark GJ, Levine BW. Idiopathic pulmonary fibrosis in monozygotic twins. The importance of genetic predisposition. Chest 1980; 78: 591–594.
5. Peabody J, Peabody JW, Hayes EW, Hayes EW. Idiopathic pulmonary fibrosis: its occurrence in identical twin sisters. 1950; 18: 330–344.
6. Hughes EW. Familial interstitial pulmonary fibrosis. Thorax 1964; 19: 515–525.
7. Bitterman PB, Rennard SI, Keogh BA, Wewers MD, Adelberg S, Crystal RG. Familial idiopathic pulmonary fibrosis: evidence of lung inflammation in unaffected members. N Engl J Med 1986; 314: 1343–1347.
8. McKusick VA, Fisher AM. Congenital cystic disease of the lung with progressive pulmonary fibrosis and carcinomatosis. Ann Intern Med 1958; 48: 774–790.
9. Adelman AG, Chertkow G, Hayton RC. Familial fibrocystic pulmonary dysplasia: a detailed family study. Can Med Assoc J 1966; 95: 603–610.
10. Bonanni PP, Frymoyer JW, Jacox RF. A family study of idiopathic pulmonary fibrosis. A possible dysproteinemic and genetically determined disease. Am J Med 1965; 39: 411–421.
11. MacMillan J. Familial pulmonary fibrosis. Chest 1951; 20: 426–436.
12. Swaye P, van Ordstrand HS, McCormack LJ, Wolpaw SE. Familial Hamman- Rich syndrome. Chest 1969; 55: 7–12.
13. Solliday NH, Williams JA, Gaensler EA, Coutu RE, Carrington C. Familial chronic interstitial pneumonia. Am Rev Respir Dis 1973; 108: 193–204.
14. Koch B. Familial fibrocytic pulmonary dysplasia: observations in one family. Can Med Assoc J 1965; 92: 801–808.
15. Nogee LM, Dunbar AE, III, Wert SE, Askin F, Hamvas A, Whitsett JA. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001; 344: 573–579.
16. Marshall R, Puddicombe A, Cookson W, Laurent G. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax 2000; 55: 143–146.
17. Depinho RA, Kaplan KL. The Hermansky-Pudlak syndrome: report of three cases and review of pathophysiology and management considerations. Medicine 1985; 64: 192–202.
18. Riccardi V. Von Recklinghausen neurofibromatosis. N Engl J Med 1981; 305: 1617–1627.
19. Malik S, Pardee N, Martin C. Involvement of the lung in tuberous sclerosis. Chest 1970; 58: 538–540.
20. Harris J, Waltuck B, Swenson E. The pathophysiology of the lungs in tuberous sclerosis.Acase report and literature review. AmRev RespirDis 1969; 100: 379–387.
21. Terry R, Sperry W, Brodoff B. Adult lipoidosis resembling Neimann-Pick disease. Am J Pathol 1954; 30: 263–286.
22. Schneider E, Epstein C, Kaback M, Brandes D. Severe pulmonary involvement in adult Gaucher’s disease: report of three cases and review of the literature. Am J Med 1977; 63: 475–480.
23. Auwerx J, Demedts M, Bouillon R, Desmet J. Coexistence of hypocalciuric hypercalcaemia and interstitial lung disease in family: a cross-sectional study. Eur J Clin Invest 1986; 15: 6–14.
24. Gerritsen S, Akkerman J, Sixma J, Witkop C, White J. The Hermansky-Pudlak syndrome. Evidence for a lowered 5-hydroxytryptamine content in platelets of heterozygotes. Scand J Haematol 1977; 18: 249.
25. Schinella RA, Greco MA, Corbert BL, Denmark LW, Cox RP. Hermansky- Pudlak syndrome with granulomatous colitis. Ann Intern Med 1980; 92: 20–23.
26. Witkop C, Townsend D, Bitterman P, Harmon K. The role of ceroid in lung and gastrointestinal disease in Hermansky-Pudlak syndrome. Adv Exp Med Biol 1989; 266: 283–297.
27. Harmon KR, Witkop CJ, White JG, King RA, Peterson M, Moore D, Tashjian J, Marinelli WA, Bitterman PB. Pathogenesis of pulmonary fibrosis: platelet-derived growth factor precedes structural alterations in the Hermansky-Pudlak syndrome. J Lab Clin Med 1994; 123: 617–627.
28. Martinet Y, Rom WN, Grotendorst GR, Martin GR, Crystal RG. Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N Engl J Med 1987; 317: 202–209.
29. Shaw R, Benedict SH, Clark RAF, King TE. Pathogenesis of pulmonary fibrosis in interstitial lung disease. Alveolar macrophage PDGF(B) gene activation and up-regulation by interferon gamma. Am Rev Respir Dis 1991; 143: 167–173.
30. Nagaoka I, Trapnell BC, Crystal RG. Upregulation of platelet-derived growth factor-A and -B gene expression in alveolar macrophages of individuals with idiopathic pulmonary fibrosis. J Clin Invest 1990; 85: 2023–2027.
31. Antoniades HN, Bravo MA, Avila RE, Galanopoulos T, Neville-Golden J, Maxwell M, Selman M. Platelet-derived growth factor in idiopathic pulmonary fibrosis. J Clin Invest 1990; 86: 1055–1064.
32. Selikoff IJ, Churg J, Hammond EC. The occurrences of asbestosis among insulation workers in the United States. Ann NY Acad Sci 1965; 132: 139–155.
33. Harries P. Asbestos hazards in naval dockyards. Ann Occup Hyg 1968; 11: 135–145.
34. Liddell FDK, Gibbs GW, McDonald JC. Radiological changes and fibre exposure in chrysotile workers aged 60–69 years at Thetford mines. Ann Occup Hyg 1982; 26: 889–898.
35. Murphy RL, Ferris BG, Burgess WA, Worcester J, Gaensler E. Effects of low concentrations of asbestos. Clinical, environmental, radiologic and epidemiologic observations in shipyard pipe converters and controls. N Engl J Med 1971; 285: 1271–1278.
36. Selikoff IJ, Nicholson WJ, Lilis R. Radiological evidence of asbestos disease among ship repair workers. Am J Ind Med 1980; 1: 9–22.
37. Berry G, Gilson JC, Holmes S, Lewinson HC, Roach SA. Asbestosis: a study of dose-response relationships in an asbestos textile factory. Br J Ind Med 1979; 36: 98–112.
38. Weill H, Waggenspack C, Bailey W, Ziskind M, Rossiter C. Radiographic and physiologic patterns among workers engaged in manufacture of asbestos cement products. J Occup Med 1973; 15: 248–252.
39. Rubino GF, Newhouse M, Murray R, Scansetti G, Piolatto G, Aresini G. Radiologic changes after cessation of exposure among chrysotile asbestos workers in Italy. Ann NY Acad Sci 1979; 330: 157–161.
40. Suorant H, Huuskonen MS, Zitting A, Juntunen J. Radiographic progression of asbestosis. Am J Ind Med 1982; 3: 67–74.
41. Rossiter CE, HEath JR, Harries PG. Royal naval dockyards asbestosis research project: nine-year follow-up study of men exposed to asbestos in Devonport dockyard. J R Soc Med 1980; 72: 337–344.
42. Rossi G, Szapiel S, Ferrans V, Crystal R. Susceptibility to experimental interstitial lung disease is modified by immune- and non-immune related genes. Am Rev Respir Dis 1987; 135: 448–455.
43. Schrier D, Kunkel R, Phan S. The role of strain variation in murine bleomycininduced pulmonary fibrosis. Am Rev Respir Dis 1983; 127: 63–66.
44. Corsini E, Luster MI, Mahler J, Craig WA, Blazka ME, Rosenthal GJ. A protective role for T lymphocytes in asbestos-induced pulmonary inflammation and collagen deposition. Am J Respir Cell Mol Biol 1994; 11: 531–539.
45. Ortiz LA, Lasky J, Hamilton RF, Jr., Holian A, Hoyle GW, Banks W, Peschon JJ, Brody AR, Lungarella G, Friedman M. Expression of TNF and the necessity of TNF receptors in bleomycininduced lung injury in mice. Exp Lung Res 1998; 24: 721–743.
46. Brass DM, Hoyle GH, Poovey HG, Liu J-Y, Brody AR. Reduced tumor necrosis factor-alpha and transforming growth factor-beta1 expression in the lungs of inbred mice that fail to develop fibroproliferative lesions consequent to asbestos exposure. Am J Pathol 1999; 154: 853–862.
47. Harrison JH, Jr., Lazo JS. Plasma and pulmonary pharmacokinetics of bleomycin in murine strains that are sensitive and resistant to bleomycin-induced pulmonary fibrosis. J Pharmacol Exp Ther 1988; 247: 1052–1058.
48. Filderman AE, Lazo JS. Murine strain differences in pulmonary bleomycin metabolism. Biochem Pharmacol 1991; 42: 195–198.
49. Harrison J, Hoyt D, Lazo J. Acute pulmonary toxicity of bleomycin: DNA scission and matrix protein mRNA levels in bleomycin-sensitive and -resistant strains of mice. Mol Pharmacol 1989; 36: 231–238.
50. Proietti E, Vanden Broecke C, Di Marzio P, Gessani S, Gresser I, Tovey MG. Specific interferon genes are expressed in individual cells in the peritoneum and bone marrow of normal mice. J Interferon Res 1992; 12: 27–34.
51. Raj NBK, Cheung SC, Rosztoczy I, Pitha P. Mouse genotype affects inducible expression of cytokine genes. J Immunol 1992; 148: 1934–1940.
52. Zawatzky R, Wurmbaeck H. Down regulation of Newcastle disease virus (NDV)–dependent IFN-alpha/beta production in macrophages by IFN-induced gene products of the locus If-1. Res Immunol 1992; 143: 57–63.
53. Heinzel FP, Sadick MD, Mutha SS, Locksley RM. Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc Natl Acad Sci USA 1991; 88: 7011–7015.
54. Phan SH, Kunkel SL. Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp Lung Res 1992; 18: 29–43.
55. Rossi GA, Hunninghake GW, Kawanami O, Ferrans VJ, Hansen CT, Crystal RG. Motheaten mice—an animal model with an inherited form of interstitial lung disease. Am Rev Respir Dis 1985; 131: 150–158.
56. Thrall RS, Vogel SN, Evans R, Shultz LD. Role of tumor necrosis factor-alpha in the spontaneous development of pulmonary fibrosis in viable motheaten mutant mice. Am J Pathol 1997; 151: 1303–1310.
57. Barzo P. Famial idiopathic fibrosig alveolitis. Eur J Respir Dis 1985; 66: 350–352.
58. Murphy A, O’Sullivan BJ. Familial fibrosing alveolitis. Ir J Med Sci 1981; 150: 204–209.
59. Beaumont F, Jansen HM, Elema JD, ten Kate LP, Sluiter HJ. Simultaneous occurrence of pulmonary interstitial fibrosis and alveolar cell carcinoma in one family. Thorax 1981; 36: 252–258.
60. McDonnell L, Sweeney EC, Jagoe WS, FitzGerald MX. Familial pulmonary fibrosis and lung cancer. Ir J Med Sci 1982; 151: 315–317.
61. Raghu G. Idiopathic pulmonary fibrosis. A rational clinical approach. Chest 1987; 92: 148–154.
62. Katzenstein A, Myers J. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998; 157: 1301–1315.
63. Hunninghake GW, Zimmerman MB, Schwartz DA, King TE, Jr., Lynch J, Hegele R, Waldron J, Colby T, Muller N, Lynch D, Galvin J, Gross B, Hogg J, Toews G, Helmers R, Cooper JA, Jr., Baughman R, Strange C, Millard M. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001; 164: 193–194.
64. Khalil N, O’Connor RN, Unruh HW, Warren PW, Flanders KC, Kemp A, Bereznay OH, Greenberg AH. Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 1991; 5: 155–162.
65. Kapanci Y, Desmouliere A, Pache J-C, Redard M, Gabbiani G. Cytoskeletal protein modulation in pulmonary alveolar myofibroblasts during idiopathic pulmonary fibrosis. Possible role of transforming growth factor beta and tumor necrosis factor alpha. Am J Respir Crit Care Med 1994; 152: 2163–2169.
66. El-Gamel A, Awad MR, Hasleton PS, Yonan NA, Hutchinson JA, Campbell CS, Rahman AH, Deiraniya AK, Sinnott PJ, Hutchinson IV. Transforming growth factor-beta (TGF-beta1) genotype and lung allograft fibrosis. J Heart Lung Transplant 1999; 18: 517–523.
67. Awad MR. Genotypic variation in the transforming growth factor-b1 gene. Transplantation 1998; 66: 1014–1020.
68. Broekelmann TJ, Limper AH, Colby TV, McDonald JA. Transforming growth factor b1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA 1991; 88: 6642–6646.
69. Limper AH, Broekelmann TJ, Colby TV, Malizia G, McDonald JA. Analysis of local mRNA expression for extracellular matrix proteins and growth factors using in situ hybridization in fibroproliferative lung disorders. Chest 1991; 99: 55S–56S.
70. Avila JJ, Lympany PA, Pantelidis P, Welsh KI, Black CM, du Bois RM. Fibronectin gene polymorphisms associated with fibrosing alveolitis in systemic sclerosis. Am J Respir Cell Mol Biol 1999; 20: 106–112.
71. Bloor CA, Knight RA, Kedia RK, Spiteri MA, Allen JT. Differential mRNA expression of insulin-like growth factor-1 splice variants in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med 2001; 164: 265–272.
72. Whyte M, Hubbard R, Meliconi R, Whidborne M, Eaton V, Bingle C, Timms J, Duff G, Facchini A, Pacilli A, Fabbri M, Hall I, Britton J, Johnston I, Di Giovine F. Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms. Am J Respir Crit Care Med 2000; 162: 755–758.
73. Pantelidis P, Fanning GC, Wells AU, Welsh KI, Du Bois RM. Analysis of tumor necrosis factor-alpha, lymphotoxin-alpha, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001; 163: 1432–1436.
74. Freeburn RW, Kendall H, Dobson L, Egan J, Simler NJ, Millar AB. The 30 untranslated region of tumor necrosis factor-alpha is highly conserved in idiopathic pulmonary fibrosis (IPF). Eur Cytokine Netw 2001; 12: 33–38.
75. Hutyrova B, Pantelidis P, Drabek J, Zurkova M, Kolek V, Lenhart K, Welsh KI, Du Bois RM, Petrek M. Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002; 165: 148–151.
76. Awad M, Pravica V, Perrey C, El Gamel A, Yonan N, Sinnott PJ, Hutchinson IV. CA repeat allele polymorphism in the first intron of the human interferongamma gene is associated with lung allograft fibrosis. Hum Immunol 1999; 60: 343–346.
77. Elias JA, Freundlich B, Kern JA, Rosenbloom J. Cytokine networks in the regulation of inflammation and fibrosis in the lung. Chest 1990; 97: 1439–1445.
78. Bienkowski RS, Gotkin MG. Control of collagen deposition in mammalian lung. Proc Soc Exp Biol Med 1995; 209: 118–140.
79. Gurujeyalakshmi G, Giri SN. Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression. Exp Lung Res 1995; 21: 791–808.
80. Ziesche R, Hofbauer E, Wittmann K, Petkov V, Block L. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 1999; 341: 1264–1269.
81. Marshall RP, McAnulty RJ, Laurent GJ. Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am J Respir Crit Care Med 2000; 161: 1999–2004.
82. Morrison CD, Papp AC, Hejmanowski AQ, Addis VM, Prior TW. Increased D allele frequency of the angiotensin-converting enzyme gene in pulmonary fibrosis. Hum Pathol 2001; 32: 521–528.
83. Hojo S, Fujita J, Yamadori I, Kamei T, Yoshinouchi T, Ohtsuki Y, Okada H, Bandoh S, Yamaji Y, Takahara J, Fukui T, Kinoshita M. Heterogeneous point mutations of the p53 gene in pulmonary fibrosis. Eur Respir J 1998; 12: 1404–1408.
84. Vassilakis DA, Sourvinos G, Spandidos DA, Siafakas NM, Bouros D. Frequent genetic alterations at the microsatellite level in cytologic sputum samples of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2000; 162: 1115–1119.
85. Geddes DM, Webley M, Brewerton DA, Turton CW, Turner-Warwick M, Murphy AH, Ward MA. A1-Antitrypsin phenotypes in fibrosing alveolitis and rheumatoid arthritis. Lancet 1977: 1049–1050.
86. Michalski JP, McCombs C, Scopelitis E, Biundo JJ, Medsger TA. Alpha1- antitrypsin pheontypes, including M subtypes, in pulmonary disease associated with rheumatoid arthritis and systemic sclerosis. Arthritis Rheum 1986; 29: 586–591.
87. Varpela E, Tiilikainen A, Varpela M, Tukianien P. High prevalences of HLA-B15 and HLA-Dw6 in patients with cryptogenic fibrosing alveolitis. Tissue Antigens 1979; 14: 68–71.
88. Hakala M, Ruuska P, Hameenkorpi R, Tiilikainen A, Ilonen J, Makitalo R. Diffuse interstitial lung disease in rheumatoid arthritis. Scand J Rheumatol 1986; 15: 368–376.
89. Libby DM, Gibofsky A, Fotino M, Waters SJ, Smith JP. Immunogenetic and clinical findings in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1983; 127: 618–622.
90. Wise RA, Wigley FM, Scott TE, Hochberg MC. HLA-DQw alloantigens and pulmonary dysfunction in rheumatoid arthristis. Chest 1988; 94: 609–614.
91. Musk A, Zilko P, Manners P, Kay P, Kamboh M. Genetic studies in familial fibrosing alveolitis. Possible linkage with immunoglobulin allotypes (gm). Chest 1986; 89: 206–210.
92. Fulmer J, Sposovska M, von Gal E, Crystal R, Mittal K. Distribution of HLA antigens in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1978; 118: 141–147.
93. Thomas AQ, Lane K, Phillips J, III, Prince M, Markin C, Speer M, Schwartz DA, Gaddipati R, Marney A, Johnson J, Roberts R, Haines J, Stahlman M, Loyd JE. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med 2002; 165: 1322–1328.
94. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL. Identification of the cystic fibrosis gene. cloning and characterization of complementary DNA. Science 1989; 245: 1066–1073.
95. Thompson LM, Plummer S, Schalling M, Altherr MR, Gusella JF, Housman DE, Wasmuth JJ. A gene encoding a fibroblast growth factor receptor isolated from the Huntington disease gene region of human chromosome 4. Genomics 1991; 11: 1133–1142.
96. Speer M. Genetic linkage: concepts and methods. In: Alberts M, ed. Genetics of Cerebrovascular Disease. Armonk, NY: Futura, 1999, 19–40.
97. Massaro D, Katz S. Fibrosing alveolitis: its occurrence, roentgenographic, and pathologic features in von Recklinghausen’s neurofibromatosis. Am Rev Respir Dis 1966; 93: 934–942.
98. Burkhalter JL, Morano JU, McCay MB. Diffuse interstitial lung disease in neurofibromatosis. South Med J 1986; 79: 944–946.
99. Webb W, Goodman P. Fibrosing alveolitis in patients with neurofibromatosis. Radiology 1966; 122: 289–293.
100. Alper J, Kegel M. Skin signs in pulmonary disease. Clin Chest Med 1987; 8: 299–310.
101. Crowe F. Axillary freckling as a diagnostic aid in neurofibromatosis. Ann Intern Med 1964; 61: 1142–1143.
102. Israel-Asselain R, Chebat J, Sors C, et al. Diffuse interstitial pulmonary fibrosis in a mother and son with von Recklinghausen’s disease. Thorax 1965; 20: 153–157.
103. Unger PD, Geller GA, Anderson PJ. Pulmonary lesions in a patient with neurofibromatosis. Arch Pathol Lab Med 1984; 108: 654–657.
104. Klatte EC, Franken EA, Smith JA. The radiographic spectrum in neurofibromatosis. Semin Roentgenol 1976; 11: 17–33.
105. Davis SA, Kaplan RL. Neurofibromatosis and interstitial lung disease. Arch Dermatol 1978; 114: 1368–1369.
106. Patchefsky AS, Atkinson WG, Hoch WS, Gordon G, Lipshitz HI. Interstitial pulmonary fibrosis and von Recklinghausen’s disease. An ultrastructural and immunofluorescent study. Chest 1973; 64: 459–464.
107. De Scheerder I, Elinck W, Van Renterghem D, Cuvelier C, Tasson J, Van der Straeten M. Desquamative interstitial pneumonia and scar cancer of the lung complicating generalised neurofibromatosis. Eur J Respir Dis 1984; 65: 623–626.
108. Porterfield JK, Pyeritz RE, Traill TA. Pulmonary hypertension and interstitial fibrosis in von Recklinghausen neurofibromatosis. Am J Med Genet 1986; 25: 531–535.
109. Medley BE, McLeod RA, Houser OW. Tuberous sclerosis. Semin Roentgenol 1976; 11: 35–54.
110. Dwyer JM, Hickie JB, Garvan J. Pulmonary tuberous sclerosis. Report of three patients and a review of the literature. Q J Med 1971; 40: 115–125.
111. Mestres CA, Catalan M, Letang E, Pujol A, Ribalta MT, Bombi JA, Canalis E, Callejas MA, Sanchez-Lloret J. Tuberous sclerosis and associated pleuropulmonary lesions. Thorac Cardiovasc Surg 1983; 31: 243–246.
112. Liberman BA, Chamberlain DW, Goldstein RS. Tuberous sclerosis with pulmonary involvement. Can Med Assoc J 1984; 130: 287–289.
113. Marshall D, Saul G, Sach E. Tuberous sclerosis. A report of 16 cases in two family trees revealing genetic dominance. N Engl J Med 1959; 262: 1102–1103.
114. Monaghan HP, Krafchik BR, MacGregor DL, Fitz CR. Tuberous sclerosis complex in children. Am J Dis Child 1981; 135: 912–917.
115. Jao J, Gilbert S, Messer R. Lymphangiomyoma and tuberous sclerosis. Cancer 1972; 29: 1188–1192.
116. Capron F, Ameille J, Leclerc P, Mornet P, Barbagellata M, Reynes M, Rochemaure J. Pulmonary lymphangioleiomyomatosis and Bourneville’s tuberous sclerosis with pulmonary involvement: the same disease? Cancer 1983; 52: 851–855.
117. Stovin PG, Lum LC, Flower CD, Darke CS, Beeley M. The lungs in lymphangiomyomatosis and in tuberous sclerosis. Thorax 1975; 30: 497–509.
118. Valensi QJ. Pulmonary lymphangiomyoma, a probable forme frust of tuberous sclerosis. A case report and survey of the literature. Am Rev Respir Dis 1973; 108: 1411–1415.
119. Schwarz M. Unusual causes of interstitial lung disease. In: Schwarz M, King TJ, eds. Interstitial Lung Disease. Philadelphia: BC Decker, 1988.
120. Davies BH, Tuddenham EG.: Familial pulmonary fibrosis associated with oculocutaneous albinism and platelet function defect. A new syndrome. Q J Med 1976; 45: 219–232.
121. Garay SM, Gardella JE, Fazzini EP, Goldring RM. Hermansky-Pudlak syndrome: pulmonary manifestation of a ceroid storage disorder. Am J Med 1979; 66: 737–747.
122. White DA, Smith GJ, Cooper JA, Jr., Glickstein M, Rankin JA. Hermansky- Pudlak syndrome and interstitial lung disease: report of a case with lavage findings. Am Rev Respir Dis 1984; 130: 138–141.
123. Schinella RA, Greco MA, Garay SM, lackner H, Wolman SR, Fazzini EP. Hermansky-Pudlak syndrome: a clinicopathologic study. Hum Pathol 1985; 16: 366–376.
124. White JG, Gerrard JM. Ultrastructural features of abnormal blood platelets. A review. Am J Pathol 1976; 83: 589–632.
125. White JG, Edson JR, Desnick SJ, Witkop CJ, Jr. Studies of platelets in a variant of the Hermansky-Pudlak syndrome. Am J Pathol 1971; 63: 319–332.
126. Witkop CJ, Krumwiede M, Sedano H, White JG. Reliability of absent platelet dense bodies as a diagnostic criterion for Hermansky-Pudlak syndrome. Am J Hematol 1987; 26: 305–311.
127. Shanahan F, Randolph L, King R, Oseas R, BRogan M, Witkop C, Rotter J, Targan S. Hermansky-Pudlak syndrome: an immunologic assessment of 15 cases. Am J Med 1988; 85: 823–828.
128. Leitman BS, Balthazar EJ, Garay SM, Naidich DP, McCauley DI. The Hermansky-Pudlak syndrome: radiographic features. Can Assoc Radiol J 1986; 37: 42–45.
129. Luisetti M, Fiocca R, Pozzi E, De Rose V, Magrini U, Grassi C. The Hermansky-Pudlak syndrome. A case with macrophage-neutrophil alveolitis. Eur J Respir Dis 1986; 68: 301–305.
130. Smith RL, Hutchins GM, Sack GH, Jr., Ridolfi RL. Unusual cardiac, renal and pulmonary involvement in Gaucher’s disease. Interstitial glucocerebroside accumulation, pulmonary hypertension and fatal bone marrow embolization. Am J Med 1978; 65: 352–360.
131. Roberts WC, Fredrickson DS. Gaucher’s disease of the lung causing severe pulmonary hypertension with associated acute recurrent pericarditis. Circulation 1967; 35: 783–789.
132. Brady RO, Kanfer JN, Bradley RM, Shapiro D. Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher’s disease. J Clin Invest 1966; 45: 1112–1115.
133. Matoth Y, Fried K. Chronic Gaucher’s disease; clinical observations on 34 patients. Isr J Med Sci 1965; 1: 521–530.
134. Myers B. Gaucher’s disease of the lungs. BMJ 1937; 2: 8–12.
135. Beutler E, Kay A, Saven A, Garver P, Thurston D, Dawson A, Rosenbloom B. Enzyme replacement therapy for Gaucher disease. Blood 1991; 78: 1183–1189.
136. Rosenberg DM. Inherited forms of interstitial lung disease. Clin Chest Med 1982; 3: 635–641.
137. Lachman R, Crocker A, Schulman J, Strand R. Radiological findings in Niemann-Pick disease. Radiology 1973; 108: 659–664.
138. Coussement A, Aiem A, Forderer A, Albertini M. [The pure visceral form of Niemann-Pick disease in children. Review of the literature apropos of a case.] J Radiol 1988; 69: 783–785.
139. Pin I, Pradines S, Pincemaille O, Frappat P, Brambilla E, Vanier MT, Bost M. [A fatal respiratory form of type C Niemann-Pick disease.] Arch Fr Pediatr 1990; 47: 373–375.
140. Bouziani A, Cheikh R, Ben Rejeb A, Khedhiri F, Ben Hamadi F, Gabsi S, Ben Mustapha M, Ben Kirane M, Ben Hassine K. [Thoracic computed tomography data and cytology of the bronchoalveolar lavage fluid in an adult case of Niemann-Pick disease. The physiognomy of the disease in Tunisia.] Rev Mal Respir 1990; 7: 267–271.
141. Demedts M, Auwerx J, Goddeeris P, Bouillon R, Gyselen A, Lauweryns JM. The inheritied association of interstitial lung disease, hypocalciuric and defective granulocyte function. Am Rev Respir Dis 1985; 131: 470–475.
142. Dupond JL, De Wazieres B, Morin G, Vuitton D. [Interstitial pneumopathy, hypocalciuric hypercalcemia and defective granulocyte function: a new case.] Presse Med 1991; 20: 33.
143. Demedts M, Bouillon R, Goddeeris P, et al. Familial pulmonary fibrosis with hypocalciuric hypercalcemia. Chest 1979; 76: 350